Our goal is to empower you with the knowledge to make informed decisions
BAS/1/1624-01-01, FCC/1/1976-20-01, FCC/1/1976-26-01, and Contract No#OSR 4129
It is formed in the body as a result of P-oxidation of valproates in the liver with the participation of isoenzymes CYP2A6, CYP2C9, and CYP2B
It has greater affinity to GIP receptors, rather than GLP-1 receptors, while its t of approximately 5 days allows once-weekly subcutaneous administration [9]
* Correspondence: Haifeng Liu, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers